Agenda for the September 2023 PBAC intracycle meeting

25 August 2023 - The agenda for the September 2023 PBAC intracycle meeting is now available. ...

Read more →

Public Summary Documents – May 2023 PBAC meeting

25 August 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2023 PBAC ...

Read more →

Updates to the Health Technology Assessment Policy and Methods Review including consultation 1 responses published

23 August 2023 - Responses to the first public consultation for the HTA Review (Consultation 1) have now been published ...

Read more →

Recommendations made by the PBAC (July 2023)

18 August 2023 - Recommendations made by the PBAC in July 2023 relating to the listing of medicines on the ...

Read more →

Estimating overall survival in people receiving PBS listed cancer medicines in Australian clinical practice

18 August 2023 - In September 2021, the Department of Health and Aged Care contracted the Medicines Intelligence Centre for ...

Read more →

New treatments for people with chronic migraine and soft tissue sarcoma added to the PBS

14 August 2023 - From August 2023, Australians with chronic migraine and soft tissue sarcoma will have access to new ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (August 2023)

14 August 2023 - Additional documents are now available. ...

Read more →

Medicine costs to halve after Labor wins 60 day dispensing vote

10 August 2023 - More than six million Australians will have the cost of their medi­cines halved within weeks as ...

Read more →

Senate showdown on 60 day dispensing

9 August 2023 - Health Minister Mark Butler has accused the Coalition and Pharmacy Guild of Australia of wanting to ...

Read more →

Negotiations for an eighth Community Pharmacy Agreement

7 August 2023 - Negotiations for an eighth Community Pharmacy Agreement 8CPA will soon commence. ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (July 2023)

2 August 2023 - Multiple new documents are now available. ...

Read more →

Global sarcoma therapy now listed on Pharmaceutical Benefits Scheme

31 July 2023 - Yondelis (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 August 2023

1 August 2023 - The August 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

International harmonisation of ingredient names - changes to the PBS Schedule effective 1 August 2023

PBAC - The PBS Schedule has been updated in the 1 August 2023 Schedule to show sole ingredient names for ...

Read more →

DoH publishes agenda for November 2023 PBAC meeting

26 July 2023 - The agenda for the November 2023 PBAC meeting is now available. ...

Read more →